← back to search

Michael W. Mullowney

University of Illinois Chicago · US
Area of research
Molecular Biology · Pharmacology
Research interest
Research interests include Gut microbiota and health, Microbial Natural Products and Biosynthesis, Genomics and Phylogenetic Studies, and Clostridium difficile and Clostridium perfringens research.
h-index
13
citations
2,062
works
36
NIH funding
primary concept
email

Recent publications

Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease
Gastro Hep Advances 2025cited by 5position: middledoi
Fecal metabolite profiling identifies critically ill patients with increased 30-day mortality
Science Advances 2025cited by 5position: middledoi
Dietary- and host-derived metabolites are used by diverse gut bacteria for anaerobic respiration
Nature Microbiology 2024cited by 70position: middledoi
Microbially catalyzed conjugation of GABA and tyramine to bile acids
Journal of Bacteriology 2024cited by 15position: firstdoi
Protection against Clostridioides difficile disease by a naturally avirulent strain
Cell Host & Microbe 2024cited by 12position: middledoi
Artificial intelligence for natural product drug discovery
Nature Reviews Drug Discovery 2023cited by 369position: firstdoi
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure
Nature Communications 2022cited by 71position: middledoi
A community resource for paired genomic and metabolomic data mining
Nature Chemical Biology 2021cited by 129position: middledoi
A computational framework to explore large-scale biosynthetic diversity
Nature Chemical Biology 2019cited by 1,030position: middledoi
A Pimarane Diterpene and Cytotoxic Angucyclines from a Marine-Derived Micromonospora sp. in Vietnam’s East Sea
Marine Drugs 2015cited by 41position: firstdoi
Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward <i>Mycobacterium tuberculosis</i>
ACS Infectious Diseases 2015cited by 38position: firstdoi
Diazaquinomycins E–G, Novel Diaza-Anthracene Analogs from a Marine-Derived Streptomyces sp.
Marine Drugs 2014cited by 20position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Mary McMillin · University of Chicago4 papers (2024–2025)Ashley M. Sidebottom · University of Chicago4 papers (2024–2025)Urszula Tanouye · University of Illinois Chicago3 papers (2014–2015)Anitha Sundararajan · University of Chicago3 papers (2024–2025)Amber R. Rose · Duchossois Group (United States)3 papers (2024–2025)David Morán · University of Chicago3 papers (2024–2025)Eric G. Pamer · Mahindra and Mahindra Limited (India)3 papers (2024–2025)Eoghainín Ó hAinmhire · University of Illinois Chicago3 papers (2014–2015)Brian T. Murphy · University of Illinois Chicago3 papers (2014–2015)Joanna E. Burdette · University of Illinois Chicago3 papers (2014–2015)Jessica Little · Duchossois Group (United States)2 papers (2024–2025)Victoria Burgo · Bellevue College2 papers (2024–2025)Che Woodson · University of Chicago2 papers (2024–2025)Xiaomei Wei · Qujing Normal University2 papers (2014–2015)Rita C. Smith · Northern Illinois University2 papers (2024–2024)Matthew A. Odenwald · University of Chicago Medical Center2 papers (2024–2025)Skylar Carlson · University of Illinois Chicago1 papers (2015–2015)Joshua Stemczynski · University of Chicago1 papers (2024–2024) · 1 papers (2019–2019)Mary E. Rinella · Sungkyunkwan University1 papers (2025–2025)